136 related articles for article (PubMed ID: 19793002)
1. cIAP2 as a therapeutic target in colorectal cancer and other malignancies.
Miura K; Karasawa H; Sasaki I
Expert Opin Ther Targets; 2009 Nov; 13(11):1333-45. PubMed ID: 19793002
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of cIAP2 enhances 5-FU sensitivity through the apoptotic pathway in human colon cancer cells.
Karasawa H; Miura K; Fujibuchi W; Ishida K; Kaneko N; Kinouchi M; Okabe M; Ando T; Murata Y; Sasaki H; Takami K; Yamamura A; Shibata C; Sasaki I
Cancer Sci; 2009 May; 100(5):903-13. PubMed ID: 19302291
[TBL] [Abstract][Full Text] [Related]
3. Inhibitor of apoptosis protein family as diagnostic markers and therapeutic targets of colorectal cancer.
Miura K; Fujibuchi W; Ishida K; Naitoh T; Ogawa H; Ando T; Yazaki N; Watanabe K; Haneda S; Shibata C; Sasaki I
Surg Today; 2011 Feb; 41(2):175-82. PubMed ID: 21264751
[TBL] [Abstract][Full Text] [Related]
4. NF-kappaB inhibition reveals differential mechanisms of TNF versus TRAIL-induced apoptosis upstream or at the level of caspase-8 activation independent of cIAP2.
Diessenbacher P; Hupe M; Sprick MR; Kerstan A; Geserick P; Haas TL; Wachter T; Neumann M; Walczak H; Silke J; Leverkus M
J Invest Dermatol; 2008 May; 128(5):1134-47. PubMed ID: 17989734
[TBL] [Abstract][Full Text] [Related]
5. Targeting inhibitor of apoptosis proteins for therapeutic intervention.
Ndubaku C; Cohen F; Varfolomeev E; Vucic D
Future Med Chem; 2009 Nov; 1(8):1509-25. PubMed ID: 21426063
[TBL] [Abstract][Full Text] [Related]
6. The inhibitors of apoptosis (IAPs) and their emerging role in cancer.
LaCasse EC; Baird S; Korneluk RG; MacKenzie AE
Oncogene; 1998 Dec; 17(25):3247-59. PubMed ID: 9916987
[TBL] [Abstract][Full Text] [Related]
7. [The role of the inhibitor of apoptosis protein (IAP) family in hematological malignancies].
Grzybowska-Izydorczyk O; Smolewski P
Postepy Hig Med Dosw (Online); 2008 Feb; 62():55-63. PubMed ID: 18283236
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of hRFI inhibits 5-fluorouracil-induced apoptosis in colorectal cancer cells via activation of NF-kappaB and upregulation of BCL-2 and BCL-XL.
Konishi T; Sasaki S; Watanabe T; Kitayama J; Nagawa H
Oncogene; 2006 May; 25(22):3160-9. PubMed ID: 16407826
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of apoptosis proteins (IAPs) as potential molecular targets for therapy of hematological malignancies.
Smolewski P; Robak T
Curr Mol Med; 2011 Nov; 11(8):633-49. PubMed ID: 21902653
[TBL] [Abstract][Full Text] [Related]
10. The non-peptidomimetic IAP antagonist ASTX660 sensitizes colorectal cancer cells for extrinsic apoptosis.
Knoll G; Ehrenschwender M
FEBS Open Bio; 2021 Mar; 11(3):714-723. PubMed ID: 33484626
[TBL] [Abstract][Full Text] [Related]
11. cIAP1, cIAP2, and XIAP act cooperatively via nonredundant pathways to regulate genotoxic stress-induced nuclear factor-kappaB activation.
Jin HS; Lee DH; Kim DH; Chung JH; Lee SJ; Lee TH
Cancer Res; 2009 Mar; 69(5):1782-91. PubMed ID: 19223549
[TBL] [Abstract][Full Text] [Related]
12. IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis.
Varfolomeev E; Blankenship JW; Wayson SM; Fedorova AV; Kayagaki N; Garg P; Zobel K; Dynek JN; Elliott LO; Wallweber HJ; Flygare JA; Fairbrother WJ; Deshayes K; Dixit VM; Vucic D
Cell; 2007 Nov; 131(4):669-81. PubMed ID: 18022362
[TBL] [Abstract][Full Text] [Related]
13. Induction of apoptosis in estrogen receptor-negative breast cancer cells by natural and synthetic cyclopentenones: role of the IkappaB kinase/nuclear factor-kappaB pathway.
Ciucci A; Gianferretti P; Piva R; Guyot T; Snape TJ; Roberts SM; Santoro MG
Mol Pharmacol; 2006 Nov; 70(5):1812-21. PubMed ID: 16908599
[TBL] [Abstract][Full Text] [Related]
14. Inhibitor of apoptosis proteins: fascinating biology leads to attractive tumor therapeutic targets.
Varfolomeev E; Vucic D
Future Oncol; 2011 May; 7(5):633-48. PubMed ID: 21568679
[TBL] [Abstract][Full Text] [Related]
15. Violacein synergistically increases 5-fluorouracil cytotoxicity, induces apoptosis and inhibits Akt-mediated signal transduction in human colorectal cancer cells.
Kodach LL; Bos CL; Durán N; Peppelenbosch MP; Ferreira CV; Hardwick JC
Carcinogenesis; 2006 Mar; 27(3):508-16. PubMed ID: 16344270
[TBL] [Abstract][Full Text] [Related]
16. Rosmarinic acid sensitizes cell death through suppression of TNF-alpha-induced NF-kappaB activation and ROS generation in human leukemia U937 cells.
Moon DO; Kim MO; Lee JD; Choi YH; Kim GY
Cancer Lett; 2010 Feb; 288(2):183-91. PubMed ID: 19619938
[TBL] [Abstract][Full Text] [Related]
17. IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-kappaB as well as cell survival and oncogenesis.
Gyrd-Hansen M; Darding M; Miasari M; Santoro MM; Zender L; Xue W; Tenev T; da Fonseca PC; Zvelebil M; Bujnicki JM; Lowe S; Silke J; Meier P
Nat Cell Biol; 2008 Nov; 10(11):1309-17. PubMed ID: 18931663
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of cIAP2 contributes to 5-FU resistance and a poor prognosis in oral squamous cell carcinoma.
Nagata M; Nakayama H; Tanaka T; Yoshida R; Yoshitake Y; Fukuma D; Kawahara K; Nakagawa Y; Ota K; Hiraki A; Shinohara M
Br J Cancer; 2011 Oct; 105(9):1322-30. PubMed ID: 21952624
[TBL] [Abstract][Full Text] [Related]
19. Targeting IAP (inhibitor of apoptosis) proteins for therapeutic intervention in tumors.
Vucic D
Curr Cancer Drug Targets; 2008 Mar; 8(2):110-7. PubMed ID: 18336193
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of apoptotic proteins: new targets for anticancer therapy.
Saleem M; Qadir MI; Perveen N; Ahmad B; Saleem U; Irshad T; Ahmad B
Chem Biol Drug Des; 2013 Sep; 82(3):243-51. PubMed ID: 23790005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
